Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders May 11, 2011
Anavex First-in-Human Dosing Commenced in ANAVEX 2-73 Clinical Trial for Alzheimer’s Disease April 20, 2011
Anavex Screening Healthy Volunteers for Phase I, First-in-Human Clinical Study in Alzheimer’s disease March 31, 2011
Anavex Comments on President Obama’s Signing of National Alzheimer’s Project Act into Law January 18, 2011
